Cargando…
Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
Autores principales: | Alape-Girón, Alberto, Moreira-Soto, Andrés, Arguedas, Mauricio, Brenes, Hebleen, Buján, Willem, Corrales-Aguilar, Eugenia, Díaz, Cecilia, Echeverri, Ann, Flores-Díaz, Marietta, Gómez, Aarón, Hernández, Andrés, Herrera, María, León, Guillermo, Macaya, Román, Molina-Mora, José Arturo, Mora, Javier, Narayanan, Aarthi, Sanabria, Alfredo, Sánchez, Andrés, Sánchez, Laura, Segura, Álvaro, Segura, Eduardo, Solano, Daniela, Soto, Claudio, Stynoski, Jennifer L., Vargas, Mariángela, Villalta, Mauren, Drexler, Jan Felix, Gutiérrez, José María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450768/ https://www.ncbi.nlm.nih.gov/pubmed/34552950 http://dx.doi.org/10.3389/fmed.2021.743325 |
Ejemplares similares
-
High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021) -
In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
por: Rojas-Jiménez, Gabriel, et al.
Publicado: (2022) -
Bacterial phospholipases C with dual activity: phosphatidylcholinesterase and sphingomyelinase
por: Monturiol‐Gross, Laura, et al.
Publicado: (2021) -
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
por: León, Guillermo, et al.
Publicado: (2021) -
SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation
por: Molina-Mora, Jose Arturo, et al.
Publicado: (2021)